Thapa R., Mallick D., Biswas B., Ghosh A., Chakrabartty S., Dhar S.Henoch-Schönlein purpura triggered by falciparum cerebral malaria. Clin Pediatr (Phila). 2010;49:699-701.
2.
Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PRSequential measurements of the reticulo-endothelial system function in Henoch-Schönlein disease of childhood. Correlations with various immunological parameters. Acta Paediatr Scand.1985;74:201-206.
3.
Mibei EK, Otieno WO, Orago AS, Stoute JADistinct pattern of class and subclass antibodies in immune complexes of children with cerebral malaria and severe malarial anaemia. Parasite Immunol. 2008;30:334-341.
4.
Troye-Blomberg M., Riley EM, Kabilan L., et al. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci U S A. 1990;87:5484-5488.
5.
Liu Y., Masuda E., Blank MC, et al. Cytokine-mediated regulation of activating and inhibitory Fcγ receptors in human monocytes. J Leukoc Biol. 2005; 77:767-776.
6.
Ha TSThe role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol. 2005;20:149-153.
7.
Kawasaki Y., Hosoya M., Suzuki H.Possible pathologenic role of interleukin-5 and eosino cationic protein in Henoch-Schönlein purpura nephritis. Pediatr Int. 2005;47:512-517.
8.
Henriksson P. , Hedner U., Nilsson IMFactor XIII (fibrin stabilising factor) in Henoch-Schönlein’s purpura. Acta Paediatr Scand . 1977;66:273-277.
